Assessment the effect of using autologous platelet rich plasma (PRP) in prevention of hypertrophic scar

Not Applicable

Recruiting

• Conditions: Hypertrophic scar.; Hypertrophic scar; L91.0

• Registration Number: IRCT20201007048955N2
• Lead Sponsor: Clinical Research Development Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not having diabetes
Not having autoimmune disease
Not having thrombocytopenia(platelets below 150000)
Not receiving glucocorticoids

Exclusion Criteria

Patient not referring to the doctor for surveillance
Death of the patient during the surveillance period

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hypertrophic scar score. Timepoint: 2nd, 12th and 24th weeks after surgery. Method of measurement: Based on Vancouver scar scale(VSS).